Newmont Work in process decreased by 17.1% to $165.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.6%, from $166.00M to $165.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 6.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $149.00M | $153.00M | $132.00M | $143.00M | $125.00M | $131.00M | $123.00M | $134.00M | $149.00M | $146.00M | $160.00M | $124.00M | $109.00M | $130.00M | $118.00M | $166.00M | $125.00M | $150.00M | $199.00M | $165.00M |
| QoQ Change | — | +2.7% | -13.7% | +8.3% | -12.6% | +4.8% | -6.1% | +8.9% | +11.2% | -2.0% | +9.6% | -22.5% | -12.1% | +19.3% | -9.2% | +40.7% | -24.7% | +20.0% | +32.7% | -17.1% |
| YoY Change | — | — | — | — | -16.1% | -14.4% | -6.8% | -6.3% | +19.2% | +11.5% | +30.1% | -7.5% | -26.8% | -11.0% | -26.3% | +33.9% | +14.7% | +15.4% | +68.6% | -0.6% |